The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence

BACKGROUND: The Costa Rican COVID-19 vaccination program has used Pfizer-BioNTech and Oxford-AstraZeneca vaccines. Real-world estimates of the effectiveness of these vaccines to prevent hospitalizations range from 90%-98% for two doses and from 70%-91% for a single dose. Almost all of these estimate...

Descripción completa

Detalles Bibliográficos
Autor principal: Rosero-Bixby, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128731/
https://www.ncbi.nlm.nih.gov/pubmed/35483079
http://dx.doi.org/10.2196/35054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128731/
https://www.ncbi.nlm.nih.gov/pubmed/35483079
http://dx.doi.org/10.2196/35054

Ejemplares similares